Hospitals should follow a structured antibiotic injection pathway starting from Ceftriaxone injection (Inj. GenCeft 1gm/2gm), progressing to Cefoperazone-Sulbactam injection (Inj. GenCepS 1.5gm / Inj. GenCepS Forte 3gm), then Piperacillin-Tazobactam injection (Inj. GenPiptaz 4.5gm), and finally Meropenem injection (Inj. GenMero 500mg / 1gm) based on infection severity and response.
Complete Clinical Decision
| Level | Antibiotic Injection | Example |
| Mild / Initial | Ceftriaxone injection | Inj. GenCeft 1gm |
| Moderate | Ceftriaxone injection (high dose) | Inj. GenCeft 2gm |
| Moderate–Severe | Cefoperazone-Sulbactam injection | Inj. GenCepS 1.5gm |
| Severe | Cefoperazone-Sulbactam injection (high dose) | Inj. GenCepS Forte 3gm |
| Empirical ICU | Piperacillin-Tazobactam injection | Inj. GenPiptaz 4.5gm |
| Escalation | Meropenem injection | Inj. GenMero 500mg |
| Critical | Meropenem injection (high dose) | Inj. GenMero 1gm |
Key Clinical Insight
These antibiotic injections are not alternatives.
They form a progressive escalation pathway used in daily hospital practice.
Operational Reality
- Medical supplies are available
- Prescriptions are clinically appropriate
- Supply chain is active
Everything appears stable.
The Problem
- Same medical supply purchased at different rates
- No visibility on escalation
- Expiry losses in Inj. GenCepS / Inj. GenMero and many more
- Unstructured ordering
Result: 10–20% invisible loss
The System Gap
The issue is not clinical judgment.
No structured visibility across medical supply and procurement
Our Mission
To simplify hospital procurement by making:
- Every medical supply decision visible
- Every purchase measurable
- Every pathway structured
Our Vision
To create a system where:
- Antibiotic injection use is standardized
- Procurement is transparent
- Hospitals operate with clarity
Ecosystem Layer
A procurement simplification system enables:
- Rate visibility across injections and team inspection before purchase
- Batch & expiry tracking
- Standardized escalation pathways
Without changing:
- Vendors
- Doctor autonomy
Execution Layer
- Inj. GenCeft → Entry & volume control
- Inj. GenCepS / Forte → Mid-level escalation
- Inj. GenPiptaz → Empirical ICU use
- Inj. GenMero → Precision escalation